Federal Circuit reverses infringement ruling in Shire v Watson

13-02-2017

The US Court of Appeals for the Federal Circuit has reversed and remanded a decision by a district court centring on the drug Lialda (mesalamine), a treatment for ulcerative colitis.


Shire, Watson, Federal Circuit, Lialda, patent, ANDA, FDA

LSIPR